Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom Control
Longer-term treatment with INVEGA(TM) (paliperidone) Extended-Release Tablets, a new once daily oral medication for schizophrenia, helped many patients effectively control their symptoms and maintain their improvements in personal and social functioning. These latest data are from a large, open label, international clinical trial sponsored by Janssen, L.P., the U.S. [click link for full article] (Source: Psychology / Psychiatry News From Medical News Today)

Chief Executive Office - The Cochrane Collaboration
CHIEF EXECUTIVE OFFICERTHE COCHRANE COLLABORATION Contributor#039;s Information Contributor#039;s name:nbsp; Cochrane Web Team Email address:nbsp; web@cochrane.org read more (Source: The Cochrane Collaboration - Current news at The Cochrane Collaboration)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div